StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Next Question

<< Previous

Bullboard Posts

Next >>

Comment by RelevantStockon Nov 23, 2021 2:55pm

177 Views

Post# 34158362

RE:RE:RE:RE:RE:Next Question

What information?... If you think penny stocks - especially this one - moves because of news I strongly disagree with you. Market makers control the accumulation and distribution, and they do everything they can to keep you on the wrong side of the trade. Retail buys when they are selling. Maybe this bullboard has a role to play in this? Fear and greed... Bolta